Cerebral Hyperperfusion Syndrome following Protected Carotid Artery Stenting

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="1"><hr/></td></tr><tr><td align="left">Hypertension</td></tr><tr><td align="left">High-grade stenosis with poor collateral flow</td></tr><tr><td align="left">Decreased CVR</td></tr><tr><td align="left">Increased peak flow velocity</td></tr><tr><td align="left">Contralateral carotid occlusion or high-grade stenosis</td></tr><tr><td align="left">Recent contralateral CAS or CEA within 3 months</td></tr><tr><td align="left">Periprocedural ischemia</td></tr><tr><td align="left">Presence of cerebral microangiopathy</td></tr><tr class="table-tr"><td colspan="1"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td>CAS: carotid artery stenting, CEA: carotid endarterectomy, CHS: cerebral hypertension syndrome, and CVR: cerebrovascular reactivity.<br/></td></tr></table>

Risk factors for CHS [<a href="/journals/crivam/2013/207602/#B6">6</a>–<a href="/journals/crivam/2013/207602/#B8">8</a>].

Case Reports in Vascular Medicine

tab1

Table 1

Table 1: Cerebral Hyperperfusion Syndrome following Protected Carotid Artery Stenting 